SERP1 and Sepsis: Given the capacity for Serp-1 to inhibit thrombotic, thrombolytic, and complement proteasesa, and that it functions as an inhibitor that reduces intimal plaque and arterial inflammation, Serp-1 treatment was postulated to hone to sites of protease activation in MHV68 virus-induced inflammatory vascular disease, sepsis, and DIC.